WaveMan · Form 4
Friedl-Naderer Johanna insider trades
> Search tickers & screens ⌘K
LIVE

Friedl-Naderer Johanna insider trades

Friedl-Naderer Johanna has filed 16 Form 4s with the SEC that we hold, for Dyne Therapeutics, Inc. (DYN) (Chief Commercial Officer) and Vir Biotechnology, Inc. (VIR) (EVP & Chief Operating Officer). Across all of them we count 0 purchases worth $0 and 12 sales worth $94.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($43.4K). The largest single trade was a sale of 1,482 shares of Vir Biotechnology, Inc. worth $33.8K, dated 2023-03-03. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-08 and the latest 2026-09-08.

Dyne Therapeutics, Inc. (DYN)

Chief Commercial Officer · 13 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-03-13S, sale reported on Form 4143$1.7K2025-03-13
2025-06-05S, sale reported on Form 4146$1.9K2025-06-06
2025-09-04S, sale reported on Form 4894$11.9K2025-09-08
2025-09-05S, sale reported on Form 4144$1.9K2025-09-08
2025-12-05S, sale reported on Form 4144$3.0K2025-12-05
2026-03-05S, sale reported on Form 4148$2.2K2026-03-06
2026-05-13S, sale reported on Form 4228$4.2K2026-05-14
2026-06-16S, sale reported on Form 4145$2.7K2026-06-17
2026-08-13S, sale reported on Form 4226$5.9K2026-08-17
2026-09-04S, sale reported on Form 4900$21.9K2026-09-08
2026-09-08S, sale reported on Form 4185$3.5K2026-09-08

Vir Biotechnology, Inc. (VIR)

EVP & Chief Operating Officer · 3 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-03-03S, sale reported on Form 41,482$33.8K2023-03-07
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1915598) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms